6505-01-285-5746 ( CLAFORAN IN ADD VANTAGE VIALS , NDC00039-0023-25 )

NSN Information
NSN FSC NIIN Item Name INC
6505-01-285-5746 6505 012855746 CEFOTAXIME SODIUM,USP 6666
NSN Features
MRC Parameter Characteristics
AKJA ACTIVE MEDICAMENT MEDICINAL STRENGTH 1.000 GRAMS CEFOTAXIME EQUIVALENT
CRLK PRIMARY CONTAINER CONTENT QUANTITY 1.000 GRAMS OF ACTIVE INGREDIENT
CBBL FEATURES PROVIDED STERILE
AGXW PHYSICAL FORM POWDER
FEAT SPECIAL FEATURES 15 ML GLASS VIAL HAVING A DOUBLE LEAD THREAD DESIGNED TO INTERLOCK WITH THE INLET PORT OF THE FOLLOWING DILUENT CONTAINERS; 6505-01-260-1237,6505-01-260-1238,6505-01-260-1239,6505-01-260-1241,6505-01-260-1242,AND 6505-01-260-6715
CSCW TOTAL PRIMARY CONTAINER QUANTITY 25
CXCY PART NAME ASSIGNED BY CONTROLLING AGENCY CEFOTAXIME SODIUM STERILE USP 1GM VIAL 25S
CQCT PRIMARY CONTAINER TYPE VIAL, SINGLE DOSE
Manufacturing Part Numbers (SKUs)
Part SKU Cage Status RNVC RNCC SADC DAC RNAAC
CLAFORAN IN ADD VANTAGE VIALS 04500 F 1 5 4 KX
NDC00039-0023-25 04500 F 2 3 4 KX
Manufacturers
Part SKU Cage Manufacturer Type Status
CLAFORAN IN ADD VANTAGE VIALS 04500 HOECHST-ROUSSEL PHARMACEUTICALS A F
NDC00039-0023-25 04500 HOECHST-ROUSSEL PHARMACEUTICALS A F
FLIS Identification
PMIC ADPE Code CRITL Code DEMIL Code DEMIL INTG NIIN Asgt ESD HMIC ENAC Schedule-B INC
A X A 1 09/16/1 P 3004909185 6666
FLIS Management
MOE REC Rep Code Mgmt Ctl USC Phrase Code Phrase Statement
DA C2201X- A K U/I CONTAINS 25 EA
DN 9B----- N K U/I CONTAINS 25 EA
VA V K U/I CONTAINS 25 EA
DF ------- F K U/I CONTAINS 25 EA
DS I K U/I CONTAINS 25 EA
Demilitarization Codes & Management
DML PMI HMIC ADP CC ESDC
A A P X
Miscellaneous Management
MOE (S_A) SOS AAC QUP UI SLC CIIC RC MCC SVC
DA SMS L 1 PG M U C2201X- A
DS SMS L 1 PG M U D
VA I 0 PG H U V
DF SMS L 1 PG M U ------- F
DN SMS L 1 PG M U 9B----- N
Management Control Army
MATCAT 1 MATCAT 2 MATCAT 3 MATCAT 4 5 ARC
C 2 2 01 X
Freight
NMFC NMFC SUB UFC HMC LTL LCL WCC TCC SHC ADC ACC ASH NMF DESC